Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
Recruiting · NCT05868330 · Interventional (participants receive a specific treatment) · Lead sponsor: Melinda Seering
View the official record on ClinicalTrials.gov →Interventions studied
Exparel Single Shot Interscalene BlockInterscalene Catheter
What this trial is about
Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter
Who can take part
Age range
18 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients who have or are:
- Orthopedics service patients having reverse shoulder replacement surgery
- ASA class I, II, or III.
- Patients at least 18 years old but less than 90 years old.
- Patients giving informed consent.
- Non-Emergency Surgery
Exclusion criteria
- Patients who have or are:
- An inability to cooperate during the block placement.
- Patients who do not meet criteria for a regional block: such as those on anti-coagulation,
- Significant pulmonary disease or allergy to medications used for peripheral nerve blocks (Exparel, Bupivacaine and Ropivacaine)
- Neuropathy of the planned extremity to block
- Documented Kidney Failure
- Documented Liver Failure
- A lack of or inability to give informed consent.
- Currently incarcerated.
- Pregnant
- Unable to communicate in English
- Chronic pre-operative opioid use (greater than 20 MME opioid used)
- Fracture
- Revision surgery
Where it is running
1 location listed across 1 US state.
- University of Iowa Hospital and Clinics - Iowa City, Iowa, United States